Staghorn calculi secondary to topiramate;Cálculo coraliforme secundario a topiramato

Farmacia Hospitalaria

Volumn 32, Issue 5, 2008, Pages 299-301

  Lopez Real A M ^a   Garcia Antelo M J ^a   Fernandez Couto D ^a   Lopez Facal S ^a   Rubio Nazabal, E ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TOPIRAMATE;

ADULT; ANAMNESIS; ANTICONVULSANT THERAPY; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; EPILEPSY; FEMALE; HUMAN; LETTER; NEPHROLITHIASIS;

EID: 60049093117     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(08)75952-X     Document Type: Editorial

References (9)

1. Dodgson S.J., Shank R.P., and Maryanoff B.E. Topiramato as an inhibitor of carbonic anhydrase isoenzimas. Epilepsia 41 Suppl 1 (2000) S35-S39
2. Ribacoba R. Eficacia y tolerancia del topiramato a largo plazo en la epilepsia refractaria del adulto. Rev Neurol 34 (2002) 101-105
3. Alarcón-Martínez H., Casa-Fernández C., Escudero-Rodríguez N., Cao-Avellaneda E., Domingo-Jiménez R., Puche-Mira A., et al. Nefrolitiasis y topiramato. Rev Neurol 42 (2006) 91-94
4. Hamm L. Renal handling of citrate. Kidney Int 38 (1990) 728-735
5. Weiner I.M. Diuretics and other agents employed in the mobilization of edema fluid. In: Gilman A.G., Rall T.W., and Nies T.W. (Eds). Goodman and Gilman's The Pharmacologic Basis of Therapeutics. 8th ed. (1990), Pergamon Press, New York 713-731
6. Ohkawa M., Tokunaga S., Nakashima T., Yamaguchi K., Orito M., and Hisazumi H. Composition of urinary calculi related to urinary tract infection. J Urol 148 (1992) 995-997
7. Parkitt A.M. Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis: relationship to citrate and calcium excretion. Arch Intern Med 124 (1969) 736-740
8. Faught E. Review of U.S. clinical trials of zonisamide in treatment of refractory partial-onset seizures. Epilepsia 40 Suppl 7 (1999) 94-95
9. Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 (1981) 239-245